Epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease.

Epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease.

Brief description of study

The purpose of this study is to collect information about the blood level of a specific marker (lipoprotein (a)). Similar to other blood lipids, such as the "bad cholesterol", lipoprotein (a) levels were found to be associated with the risk of hardening of the arteries, known as atherosclerosis, which leads to conditions such as heart attacks, stroke, or peripheral artery disease (severe pain in legs while walking or lower limb amputation.) 

In this study which is performed on a global scale, we will collect information from patients with these conditions to better understand what the lipoprotein (a) levels are over a broad geography. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    cardiovascular disease,heart attack,stroke,peripheral arterial disease,elevated lipoprotein (a)
  • Age: Between 18 Years - 80 Years
  • Gender: All

  • History of heart attack OR
  • History of stroke OR
  • Peripheral arterial disease

Updated on 31 Oct 2022. Study ID: 833997

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center